Case Reports
doi: 10.1016/j.athoracsur.2013.08.050.
The use of high-dose hydroxocobalamin for vasoplegic syndrome
Affiliations
- PMID: 24792267
- DOI: 10.1016/j.athoracsur.2013.08.050
Item in Clipboard
Case Reports
The use of high-dose hydroxocobalamin for vasoplegic syndrome
Ann Thorac Surg.
2014 May.
Abstract
We describe a case of hypotension on cardiopulmonary bypass for coronary artery bypass grafting, double valve repairs, and patent foramen ovale closure. The patient experienced vasoplegic syndrome while on cardiopulmonary bypass. He was treated with high-dose hydroxocobalamin (vitamin B12). His blood pressure responded rapidly, obviating any further vasopressor requirements.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.Anesth Analg. 2019 Jul;129(1):e1-e4. doi: 10.1213/ANE.0000000000003648. Anesth Analg. 2019. PMID: 29979199
-
Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.J Cardiothorac Vasc Anesth. 2017 Jun;31(3):1012-1014. doi: 10.1053/j.jvca.2016.08.019. Epub 2016 Aug 18. J Cardiothorac Vasc Anesth. 2017. PMID: 27838199 No abstract available.
-
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890. Am J Case Rep. 2021. PMID: 34143764 Free PMC article.
-
Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.J Card Surg. 2021 Oct;36(10):3749-3760. doi: 10.1111/jocs.15805. Epub 2021 Jul 12. J Card Surg. 2021. PMID: 34251716
-
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1519-25. doi: 10.1586/erc.11.160. Expert Rev Cardiovasc Ther. 2011. PMID: 22103871 Review.
Cited by
-
High-dose hydroxocobalamin in end-stage liver disease and liver transplantation.Drugs Ther Perspect. 2019;35(9):442-446. doi: 10.1007/s40267-019-00643-7. Epub 2019 Jun 11. Drugs Ther Perspect. 2019. PMID: 32288505 Free PMC article.
-
Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia.Cureus. 2023 May 1;15(5):e38400. doi: 10.7759/cureus.38400. eCollection 2023 May. Cureus. 2023. PMID: 37265888 Free PMC article.
-
Exploring Horizons in the Treatment of Vasoplegia in Shock Syndromes.Eurasian J Med. 2022 Dec;54(Suppl1):168-171. doi: 10.5152/eurasianjmed.2022.22094. Eurasian J Med. 2022. PMID: 36655463 Free PMC article.
-
Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review.J Tehran Heart Cent. 2017 Jan;12(1):27-31. J Tehran Heart Cent. 2017. PMID: 28469689 Free PMC article.
-
The Durability of Intravenous Hydroxocobalamin in Vasoplegia.Cureus. 2023 Apr 29;15(4):e38307. doi: 10.7759/cureus.38307. eCollection 2023 Apr. Cureus. 2023. PMID: 37255913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
